國家衛生研究院 NHRI:Item 3990099045/15386
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 856714      線上人數 : 841
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15386


    題名: TASL-TSOC Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases
    作者: Cheng, PN;Chen, WJ;Hou, CJ;Lin, CL;Chang, ML;Wang, CC;Chang, WT;Wang, CY;Lin, CY;Hung, CL;Peng, CY;Yu, ML;Chao, TH;Huang, JF;Huang, YH;Chen, CY;Chiang, CE;Lin, HC;Li, YH;Lin, TH;Kao, CH;Wang, TD;Liu, PY;Wu, YW;Liu, CJ
    貢獻者: Institute of Cellular and Systems Medicine
    摘要: Metabolic dysfunction associated fatty liver disease (MAFLD) is an increasingly important and common liver disease worldwide. The diagnosis of MAFLD is based on the presence of steatosis on image/histology/serum markers accompanied with presence of at least one of the three metabolic features that include overweight/obesity, type II diabetes mellitus, and metabolic risk factors. MAFLD is not only a liver disease but also a contributing or related factor of cardiovascular diseases (CVD) which lead to the major etiology of morbidity and mortality in patients with MAFLD. Hence, understanding the association of MAFLD and CVD, surveillance and risk stratification of MAFLD in patients with CVD, and current status of management of MAFLD are urgently needed for both hepatologist and cardiologist. The purpose of this Taiwan position statement is to review literature and provide suggestions that cover from epidemiology, etiology, risk factors, risk stratification, non-pharmacological intervention, and potential drug treatment of MAFLD, especially focusing on association with CVD.
    日期: 2024-01
    關聯: Clinical and Molecular Hepatology. 2024 Jan;30(1):16-36.
    Link to: http://dx.doi.org/10.3350/cmh.2023.0315
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2287-2728&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001186681200009
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85181726040
    顯示於類別:[王朝永] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB37793641.pdf1511KbAdobe PDF106檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋